31th PAGE Meeting

A Coruña - Spain
27-30 June, 2023

View abstracts

Home / 2023 – A Coruña – Spain / Abstracts

← Back to filters

Abstracts (17)

I-05Bram Agema

Development of covariate-informed model pooling method to predict the correct starting dose

Wednesday 10:00-11:30

I-06Ana Alarcia Lacalle

Population pharmacokinetic modelling and Monte Carlo simulation of piperacillin administered as extended infusion in critically ill patients

Wednesday 10:00-11:30

I-15Carla Bastida Fernández

Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections

Wednesday 10:00-11:30

I-18Laura Ben Olivo

Model-informed precision dosing web tool of busulfan for Brazilian pediatric patients

Wednesday 10:00-11:30

I-33Anthea Deschamps

Pharmacokinetics of cefotaxime in intensive care patients: exploration of the sources of variability with a population model

Wednesday 10:00-11:30

I-36Kevin Dykstra

Population pharmacokinetics of vadadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor for treatment of anemia associated with chronic kidney disease

Wednesday 10:00-11:30

I-37Omar Elkayal

Model-based dose optimisation of intravenous posaconazole for treatment of patients with invasive aspergillosis in the intensive care unit

Wednesday 10:00-11:30

I-57Nick Holford

A Physiological Approach to Renal Clearance – from Premature Neonates to Adults

Wednesday 10:00-11:30

I-70Sjoerd Koopman

Bayesian forecasting of recombinant factor IX-Fc fusion protein concentrate dosing in haemophilia B patients: Comparison of the performance of two population pharmacokinetic models

Wednesday 10:00-11:30

III-31Donghwan Lee

A comparative population pharmacokinetic analysis of nafamostat mesilate in patients receiving extracorporeal membrane oxygenation therapy (ECMO) support: central venous samples vs. ECMO circuit samples

Thursday 10:15-11:45

III-38Han Liu

Informing the selection of clinically relevant pharmacokinetic target range for Therapeutic Drug Monitoring (TDM) of sunitinib: a pharmacometric simulation framework

Thursday 10:15-11:45

III-49Emir Mesic

Population pharmacokinetics of Jesduvroq (daprodustat) in chronic kidney disease patients with anemia

Thursday 10:15-11:45

III-56Frances Okibedi

Investigating Alternative Daily Dose Regimens for Bedaquiline in Treatment of Multidrug-Resistant Tuberculosis using an Interactive Shiny Application

Thursday 10:15-11:45

III-74Darlene Santiago

A Pharmacometric approach for opioid use disorder in Puerto Rico: A research agenda to individualize buprenorphine pharmacotherapy.

Thursday 10:15-11:45

III-78Raman Sharma

A meta-analysis for predicting early bactericidal activity of beta-lactam antibiotics against pulmonary tuberculosis

Thursday 10:15-11:45

III-85Huybrecht T'jollyn

Individual virtual controls as surrogate for a control arm – application for siRNA and NA therapy in chronic hepatitis B infection

Thursday 10:15-11:45

III-88Paul Thoueille

Pharmacometrics-based analysis of long-acting cabotegravir over 6 months in real-life people living with HIV in Switzerland

Thursday 10:15-11:45